Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells

Atherosclerosis

Volumn 190, Issue 1, 2007, Pages 90-99

  Gutiérrez, Gisela ^a,b   Mendoza, Criselda ^c   Zapata, Estrella ^a   Montiel, Angélica ^a   Reyes, Elba ^b   Montaño, Luis Felipe ^d   López Marure, Rebeca ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d Facultad de Medicina ^*  (Mexico)

Author keywords

Cell adhesion; DHEA; Endothelial cells; Inflammation; NF B; TNF

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PRASTERONE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ATHEROSCLEROSIS; CELL ADHESION; CHEMOKINE CCL2; DEHYDROEPIANDROSTERONE; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UMBILICAL VEINS; VASCULITIS;

EID: 33845573597     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.031     Document Type: Article

References (37)

1. Regelson W., Kalimi M., and Loria M. DHEA: some thoughts as to its biological and clinical action. In: Kalimi M., and Regelson W. (Eds). The biologic role of dehidroepiandrosterone (DHEA) (1990), Walter de Gruyter & Co., Berlin, New York 405-445
2. Eich D.M., Nestler J.E., Johnson D.E., Wechsler A.S., and Hess M.L. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 8 (1993) 261-269
3. Schwartz C.J., Valente A., Sprague E., et al. The pathogenesis of atherosclerosis: an overview. Clin Cardiol 2 Suppl. 1 (1991) 1-16
4. Cominacini L., Garbin U., Pasini A.F., et al. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens 16 (1998) 1913-1919
5. Herrington D.M. Dehydroepiandrosterone and coronary atherosclerosis. Ann N Y Acad Sci 774 (1995) 271-280
6. Yoneyama A., Kamiya Y., Kawaguchi M., et al. Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells. Life Sci 60 (1997) 833-838
7. Mohan P.F., and Benghuzzi H. Effect of dehydroepiandrosterone on endothelial cell proliferation. Biomed Sci Instrum 33 (1997) 550-555
8. Zapata E., Ventura J.L., De la Cruz K., et al. Dehydroepiandrosterone inhibits the proliferation of HUVEC by enhancing the expression of p53 and p21, restricting the phosphorylation of RB, and is androgen- and estrogen-receptor independent. FEBS J 272 (2005) 1343-1353
9. Estrada A., Mendoza C., Ventura J.L., et al. NF-kappaB dependent activation of human endothelial cells treated with soluble products derived from human lymphomas. Cancer Lett 191 (2003) 239-248
10. Rothe G., and Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukoc Biol 47 (1990) 440-448
11. Aoudjit F., Brochu N., Belanger B., et al. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50. Cell Growth Differ 8 (1997) 335-342
12. Brown K., Park S., Kanno T., Franzoso G., and Siebenlist U. Mutual regulation of the transcriptional activator NF-kB and its inhibitor IκB-α. Proc Natl Acad Sci USA 90 (1993) 2532-2536
13. True A.L., Rahman A., and Malik A.B. Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 279 (2000) L302-L311
14. Hayashi T., Esaki T., Muto E., et al. Dehudroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 20 (2000) 782-792
15. Migeon C.J., Keller A.R., Lawrence B., et al. Dehydroepiandrosterone and androsterone levels in human placenta. Effect of age and sex: day-to-day and diural variations. J Clin Endocrinol Metab 17 (1957) 1051-1062
16. Gordon G.B., Bush D.E., and Weisman H.F. Reduction of atherosclerosis by administration of dehydroepiandrosterone: a study in the hypercholesterolemic New Zeland white rabbit with aortic intimal injury. J Clin Invest 82 (1988) 712-720
17. Taub D.D. Chemokine-leucocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev 7 (1996) 355-376
18. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 68 (1993) 499-508
19. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
20. Ayhan S., Tugay C., Norton S., et al. Dehydroepiandrosterone protects the microcirculation of muscle flaps from ischemia-reperfusion injury by reducing the expression of adhesion molecules. Plast Reconstr Surg 111 (2003) 2286-2294
21. Ng M.K., Nakhla S., Baoutina A., et al. Dehidroepiandrosterone, an adrenal androgen, increases human foam cell formation: a potentially pro-atherogenic effect. J Am Coll Cardiol 42 (2003) 1967-1974
22. Norata G.D., Tibolla G., Seccomandi P.M., Poletti A., and Catapano A.L. Dihydrotestosterone decreases tumor necrosis factor {alpha} and lipopolysaccharide induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab (2005) [Epub ahead of print]
23. Death A.K., McGrath K.C., Sader M.A., et al. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology 145 (2004) 1889-1897
24. Gatson J.W., Kaur P., and Singh M. Dihydrotestosterone differentially modulates the MAPK and the PI-3 kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 12 (2006) [Epub ahead of print]
25. Tak P.P., and Firestein G.S. NF-κB: a key role in inflammatory diseases. J Clin Invest 107 (2001) 7-11
26. Valen G., Yan Z.Q., and Hansson G.K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38 (2001) 307-314
27. Thornburg N.J., Pathmanathan R., and Raab-Traub N. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res 63 (2003) 8293-8301
28. Hatada E.N., Do R.K., Orlofsky A., et al. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol 171 (2003) 761-768
29. Udalova I.A., Richardson A., Denys A., et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 20 (2000) 9113-9119
30. Iwasaki Y., Asai M., Yoshida M., et al. Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 89 (2004) 3449-3454
31. Driessler F., Venstrom K., Sabat R., et al. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 135 (2004) 64-73
32. Hipp M.S., Urbich C., Mayer P., et al. Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Eur J Immunol 32 (2002) 2208-2217
33. Park S.K., Yang W.S., Han N.J., et al. Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human glomerular endothelial cells. Nephrol Dial Transplant 19 (2004) 312-319
34. Su W.B., Chang Y.H., Lin W.W., and Hsieh S.L. Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI). Exp Cell Res 312 (2006) 266-277
35. Ginis I., Hallenbeck J.M., Liu J., et al. Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Mol Med 6 (2000) 1028-1041
36. Aksoy Y., Yapanoglu T., Aksoy H., et al. The effect of dehydroepiandrosterone on renal ischemia-reperfusion-induced oxidative stress in rabbits. Urol Res 132 (2004) 93-96
37. Aragno M., Mastrocola R., Brignardello E., et al. Dehidroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. Endocrinology 143 (2002) 3250-3258